Uterine Activity in Moderate-Severe Neonatal Encephalopathy: A Case Control Study
NCT ID: NCT03122808
Last Updated: 2023-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
264 participants
OBSERVATIONAL
2016-09-01
2021-10-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The American Congress of Obstetricians and Gynecologists defines uterine tachysystole as more than 5 contractions in 10 minutes, averaged over a 30-minute window. By this definition, excessive uterine activity is common and, at best, a non-specific predictor of depressed neurological function in the newborn. There is a need for predictors of neonatal encephalopathy that are more specific and clinically applicable.
Contraction and relaxation duration are two measures that closely reflect the proposed role of excessive uterine activity in the pathogenesis of neonatal encephalopathy. Prolonged contractions with short relaxation periods result in progressive reductions in fetal cerebral oxygenation. Shorter uterine contraction periods are associated with an increased risk of low umbilical cord potential of hydrogen (pH) values.
Our primary aim is to measure parameters of uterine activity, for example relaxation and contraction duration, and determine their relationship with the risk of neonatal encephalopathy. We will also investigate how measures of uterine activity interact with other measures of labour and fetal well-being, including cervical dilation rates and fetal heart rate patterns. In babies with neonatal encephalopathy, we will investigate the relationship of uterine activity with electrophysiological, radiological and developmental outcomes.
We will perform a retrospective case-control study of babies born in the Rotunda hospital from 2005 until the present. The assessor of the Cardiotocograph (CTG) recordings will be blind to the disease status of the infants. For each recording, every uterine contraction and rest interval will be measured. Summary variables created from these measures will be used to compare the case and control groups. The primary variable will be mean rest interval duration.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections
NCT03303235
Cervical Volume by Three-Dimensional Ultrasound as a Predictor of Preterm Delivery
NCT00342550
IMPACTS OF BRAXTON-HICKS CONTRACTIONS ON COMPUTERISED CARDIOTOCOGRAPHY PARAMETERS: A POTENTIAL LINK.
NCT04417296
Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium
NCT06285409
Active Management of the Third Stage of Labour: Uterine Tonus Assessment by Midwife vs. Patient Self-administration
NCT02223806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Excessive uterine activity may be one of several aetiological factors that contribute to depressed neurological function in the newborn. During labour, uterine contractions can compress the fetal cranium at pressures high enough to impair cerebral perfusion. Contraction rates greater than 7 in 15 minutes are associated with an increased risk of neonatal encephalopathy.
The American Congress of Obstetricians and Gynecologists defines uterine tachysystole as more than 5 contractions in 10 minutes, averaged over a 30-minute window. By this definition, excessive uterine activity is common and, at best, a non-specific predictor of depressed neurological function in the newborn. There is a need for predictors of neonatal encephalopathy that are more specific and clinically applicable.
Contraction and relaxation duration are two measures that closely reflect the proposed role of excessive uterine activity in the pathogenesis of neonatal encephalopathy. Prolonged contractions with short relaxation periods result in progressive reductions in fetal cerebral oxygenation. Shorter uterine contraction periods are associated with an increased risk of low umbilical cord pH values.
Our primary aim is to measure parameters of uterine activity, for example relaxation and contraction duration, and determine their relationship with the risk of neonatal encephalopathy. We will also investigate how measures of uterine activity interact with other measures of labour and fetal well-being, including cervical dilation rates and fetal heart rate patterns. In babies with neonatal encephalopathy, we will investigate the relationship of uterine activity with electrophysiological, radiological and developmental outcomes.
We will perform a retrospective case-control study of babies born in the Rotunda hospital from 2005 until the present. Cases and controls must be over 35 weeks gestational age and have at least 15 minutes of Cardiotocograph (CTG) recording from labour available for analysis. Cases will be babies with moderate or severe neonatal encephalopathy of apparent hypoxic-ischemic aetiology. Controls will be the first healthy babies born before and after the cases to satisfy the study criteria. Controls will be matched for parity.
The assessor of the CTG recordings will be blind to the disease status of the infants. For each recording, every uterine contraction and rest interval will be measured. Summary variables created from these measures will be used to compare the case and control groups. The primary variable will be mean rest interval duration.
For further detail please see the study protocol.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neonatal encephalopathy
The inclusion criteria will be:
* Moderate or severe neonatal encephalopathy
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn
The exclusion criteria will be:
* Non-hypoxic-ischaemic aetiology or postnatal hypoxic-ischaemia
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available
Uterine Activity Analysis
Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.
Partogram Analysis
Analysis of slope of partogram
Control
The inclusion criteria will be:
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn
The exclusion criteria will be:
* APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes
* Admission to the neonatal unit
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available
Uterine Activity Analysis
Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.
Partogram Analysis
Analysis of slope of partogram
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uterine Activity Analysis
Analysis of components of uterine activity; contraction rate, length of contraction, length of relaxation and other values based off these measurements.
Partogram Analysis
Analysis of slope of partogram
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn
* Gestational age of 35+0 weeks or greater
* Singleton pregnancy
* Inborn
Exclusion Criteria
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available Controls
* APGAR score of less than 5 at 1 minute or less than 7 at 5 or 10 minutes
* Admission to the neonatal unit
* Major congenital abnormalities
* Less than 15 minutes of digital CTG recording from labour available
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Rotunda Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Breda Hayes
Consultant Neonatologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Breda Hayes, MD
Role: PRINCIPAL_INVESTIGATOR
The Rotunda Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Rotunda Hospital
Dublin, Co. Dublin, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC-2015-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.